AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Herti 150mg Injection

Prescription Icon
Prescription Required

Marketer

Hetero Healthcare Limited

Salt Composition

Trastuzumab (150mg)

Overview Herti 150mg Injection

Oncaspar 150mg Injection treats breast and gastric cancers by targeting and eliminating cancerous cells through HER2 (human epidermal growth factor receptor 2) inhibition. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your specific condition and may vary. Strict adherence to your doctor's prescribed regimen is crucial, as incorrect usage or overdosage can lead to severe adverse effects. While therapeutic benefits may not be immediately apparent (requiring weeks or months), discontinuation should only occur under medical supervision. Common side effects include nausea, headache, skin rash, sleep disturbances, and infections. This medication can decrease blood cell counts (red and white), increasing infection risk. Regular blood tests monitoring blood cell levels, cardiac function, liver health, and uric acid are necessary. Report any shortness of breath, cough, chills, or limb swelling to your doctor immediately. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and lactation; reliable contraception for both partners is essential throughout treatment.

Uses of Herti 150mg Injection

Cancers affecting the breast and stomach

Major Benefits of Herti 150mg Injection:

This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.

Common Side effects of Herti 150mg Injection:

  • Anemia (low number of red blood cells)
  • Chills
  • Common cold
  • Cough
  • Decreased blood cells (red cells, white cells, and platelets)
  • Diarrhea
  • Fatigue
  • Fever
  • Headache
  • Heart failure
  • Infection
  • Insomnia (difficulty in sleeping)
  • Mucosal inflammation
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Taste change
  • Upper respiratory tract infection
  • Weight loss

How to use Herti 150mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Herti 150mg Injection works:

Herti 150mg Injection, a monoclonal antibody of the IgG1 type, targets HER2, a human epidermal growth factor receptor protein. By binding to HER2 receptors overexpressed in breast and gastric cancers, it prevents cancerous cell growth. This action disrupts HER2 activity and subsequently blocks several downstream signaling cascades implicated in cancer development.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Herti 150mg Injection and alcohol can lead to significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Herti 150mg Injection during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. Nevertheless, in exceptional life-threatening circumstances, a physician might consider prescribing it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administering Herti 150mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Herti 150mg Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Herti 150mg Injection appears safe for individuals with kidney impairment. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Herti 150mg Injection's use in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Herti 150mg Injection :

Should you forget a dose of Herti 150mg Injection, seek your physician's advice.

Facts to Know About Herti 150mg Injection

LabelValue
Chemical Category Monoclonal antibody
Developing Habits No.
Treatment Category Cancer Medications
Action Class Monoclonal Antibody HER2/neu (ErbB2) Inhibitor

FAQs on Herti 150mg Injection

Herti 150mg Injection may cause side effects including sore throat, fever, chills, fatigue, pale skin, nosebleeds, and unusual bleeding or bruising. Other possible side effects are stomach pain, seizures, hallucinations, muscle cramps and spasms, nausea, vomiting, loss of appetite, rapid heartbeat, discolored or decreased urine output, painful urination, and signs of infection. Seek immediate medical attention if any of these occur.
Effective contraception is recommended for women of childbearing age throughout Herti 150mg Injection therapy and for seven months afterward. Pregnancy planning may resume seven months post-treatment.
Herceptin 150mg injections should be administered to early-stage breast cancer patients for one year, or until disease recurrence, whichever comes first. Treatment should not exceed one year.
Herceptin 150mg Injection does not require fasting beforehand. Administration must be supervised by an oncologist and performed only by a qualified healthcare professional.
Herti 150mg Injection is available in two formulations: intravenous (IV) infusion and subcutaneous injection. Always verify the correct formulation is administered as prescribed, as the IV formulation is exclusively for intravenous use. Your doctor may change your treatment between the IV and subcutaneous formulations if clinically indicated.
Herti 150mg Injection, a monoclonal antibody, targets the HER2 protein found on some cancer cells. Because it works by binding to HER2 to inhibit cancer growth, it's only effective in patients with HER2-positive cancer and is not indicated for use in those with HER2-negative cancer.
Using Herti 150mg Injection with anthracycline-based cancer drugs (like doxorubicin) can harm your heart. Your doctor must assess your heart health before and throughout treatment.
Cardiac evaluations are required at treatment initiation, every three months during treatment, and every six months post-treatment for up to 24 months following the final Herti 150mg Injection. Patients with pre-existing cardiac conditions require evaluation every 12 weeks.
Herti 150mg Injection
14,270
MRP 17,385
17% off